Scientific publications

Revisiting intracavitary immunotherapy of cancer. Scientific Publication

May 13, 2022 | Magazine: Clinical Cancer Research

Fernando Aranda 1 , Iñaki Eguren-Santamaria 2 , Angela Bella 1 , Pedro Berraondo 1 , Ignacio Melero 3

Abstract

Ovarian cancer is often limited to the peritoneal cavity in the form of peritoneal carcinomatosis. Peritoneal spreading offers the opportunity for locoregional delivery of combinations of immunotherapy agents, maximizing bioavailability while potentially reducing systemic exposure and side effects.

CITATION Clin Cancer Res. 2022 May 13;28(10):1993-1995. doi: 10.1158/1078-0432.CCR-22-0201.

see publication in pubmed

Our authors

Dr. Fernando Aranda Vega Curriculum

Researcher | Principal Investigator Research Group on Locoregional Immunotherapy Strategies in Peritoneal Carcinomatosis

Imagen del Dr. Ignacio Melero Bermejo, especialista en Inmunología de la Clínica Universidad de Navarra.

Dr. Ignacio Melero Bermejo Curriculum

Researcher | Principal Investigator Combination Strategies for Translational Immunotherapy Research Group

Dr. Pedro Berraondo López Curriculum

Researcher | Principal Investigator Cytokine-Based Therapeutics Research Group

Dr. Iñaki Eguren Santamaría [SP] Curriculum

Predoctoral Immunology and Immunotherapy Research Program